UBS Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.12M | Buy |
|
|||||
|
2022
Q3 | $369K | Sell |
|
|||||
|
2022
Q2 | $2.28M | Sell |
|
|||||
|
2022
Q1 | $5.78M | Buy |
|
|||||
|
2021
Q4 | $3.95M | Buy |
|
|||||
|
2021
Q3 | $3.66M | Buy |
|
|||||
|
2021
Q2 | $1.51M | Sell |
|
|||||
|
2021
Q1 | $2.44M | Buy |
|
|||||
|
2020
Q4 | $747K | Buy |
|
|||||
|
2020
Q3 | $1.15M | Buy |
|
|||||
|
2020
Q2 | $439K | Sell |
|
|||||
|
2020
Q1 | $180K | Sell |
|
|||||
|
2019
Q4 | $560K | Buy |
|
|||||
|
2019
Q3 | $218K | Buy |
|
|||||
|
2019
Q2 | $69K | Sell |
|
|||||
|
2019
Q1 | $126K | Sell |
|
|||||
|
2018
Q4 | $1.67M | Buy |
|
|||||
|
2018
Q3 | $715K | Buy |
|
|||||
|
2018
Q2 | $316K | Sell |
|
|||||
|
2018
Q1 | $2.28M | Buy |
|
|||||
|
2017
Q4 | $88K | Buy |
|
|||||
|
2017
Q3 | $3K | Sell |
|
|||||
|
2017
Q2 | $7K | Buy |
|
|||||
|
2017
Q1 | $9K | Sell |
|
|||||
|
2016
Q4 | $786K | Buy |
|
|||||
|
2016
Q3 | $986K | Buy |
|
|||||
|
2016
Q2 | $524K | Buy |
|
|||||
|
2016
Q1 | $35K | Buy |
|
|||||
|
2015
Q4 | $48K | Sell |
|
|||||
|
2015
Q3 | $50K | Buy |
|
|||||
|
2015
Q2 | $13K | Sell |
|
|||||
|
2015
Q1 | $30K | Buy |
|
|||||
|
2014
Q4 | $6K | Buy |
|